Objective: The objective of this study was to measure the RO of varying doses of CVL-354 at kappa and mu receptors in nonhuman primates using radiotracers [11C]LY27950502,3 and [11C]carfentanil ([11C]CFN), respectively
Objective: The objective of this study was to measure the RO of varying doses of CVL-354 at kappa and mu receptors in nonhuman primates using radiotracers [11C]LY27950502,3 and [11C]carfentanil ([11C]CFN), respectively
You are now leaving cerevel.com, a website provided by Cerevel Therapeutics. The content displayed on external websites is not controlled by Cerevel, and Cerevel assumes no responsibility for the information or statements on external websites.